Bullous Keratopathy Market is set to Grow at a Remarkable Pace by 2033
The global bullous keratopathy market is expected to register a CAGR of 4.3% from 2023 to 2033, reaching a valuation of US$ 427.54 Million in 2023, as per a recently published Future Market Insights report. The rising prevalence of ophthalmic diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the key factor propelling the industry's growth. According to the NCBI report, approximately 10-15% of patients diagnosed with keratoconus require to undergo a corneal implant procedure at some point.
Corneal blindness is the third-leading cause of blindness
after glaucoma and cataract affecting 10 million people globally. The
most common cause of damage to endothelium layer of the cornea is eye surgery.
Any kind of trauma, glaucoma, or inflammation from eye surgery can result in
bullous keratopathy. Bullous keratopathy may occur in around 1% to 2% of
patients undergoing cataract surgery, a nonsignificant number when you consider
that approximately 10 million patients undergo cataract surgery worldwide each
year.
Collagen-based bio-engineered artificial corneas used in
Bullous Keratopathy have high demand in the market owing to their advantages,
such as low cost, biocompatibility, and improved safety and effectiveness.
There has been an increased focus of manufacturers to develop and launch new
products. Currently, two products are in clinical trials and are expected to
help the artificial cornea segment and overall industry growth over the
forecast period. For instance, in 2022, Corneat Vision announced that its
CorNeat KPro (artificial cornea) is undergoing clinical trials. This product is
expected to receive marketing approval in 2024 which will aid in the market
expansion of Bullous Keratopathy.
Competitive Landscape
Key players in the Bullous Keratopathy market are- Hoffmann-La
Roche Ltd, Regeneron, Pharmaceuticals, Inc., Pfizer, Inc., Bayer AG, Cellusion,
CRSTEurope, Barraquer Eye Hospital, Planchard Eye & Laser Center, Medscape.
Browse
More Details@ https://www.futuremarketinsights.com/reports/bullous-keratopathy-market
Key
Segments Profiled in the Bullous Keratopathy Market Industry Survey
Bullous
Keratopathy Market by Therapies:
- Emmecell
- Drug
Description
- Regulatory
Milestones
- Safety
and Efficiency
- Product
Profile
- Cellusion
- Drug
Description
- Other
Development Activities
- Clinical
Development
- Safety
and Efficiency
- Product
Profile
Bullous
Keratopathy Market by End User:
- Hospitals
- Surgical
Centers
Bullous
Keratopathy Market by Treatment:
- Medical
Management
- Lubricants
- Steroids
- Hyperosmotic
agents
- Anti-
Glaucoma drugs
- Antibiotics
- Amniotic
Membrane Grafting (AMG)
- Annular
Keratotomy
- Anterior
Stromal Puncture
Comments
Post a Comment